Top

Published in:

Open Access 01-04-2009 | Diabetes mellitus

Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study

Authors: Lisanne Balk, Trynke Hoekstra, Jos Twisk

Published in: European Journal of Epidemiology | Issue 4/2009

Abstract

Cardiovascular diseases and diabetes mellitus type II (DM II) are both major health problems. A large risk factor for these diseases is the presence of the metabolic syndrome. It is known that the risk of DM II can be decreased by coffee consumption. Therefore, we examined the association between coffee consumption and the components of the metabolic syndrome. Prospective data from the Amsterdam Growth and Health Longitudinal Study (AGAHLS) is used to analyse the associations between coffee consumption (averaged over a period from 27 till 42 years) and the components of the metabolic syndrome (at the age of 42 years). This was done by linear regression analyses and associations were adjusted for physical activity, energy intake, alcohol consumption and smoking behaviour. The results showed that moderate and high (>2 cups/day) coffee consumption was significantly associated with lower HDL in women. For men, coffee consumption was not associated with any of the components of the metabolic syndrome.

Hu FB, van Dam RM, Liu S. Diet and risk of type II DM: the roles of type of fat and carbohydrate. Diabetologia. 2001;44:805–17.PubMedCrossRef

Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J. 2004;25:2212–9.PubMedCrossRef

van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA. 2005;294:97–104.PubMedCrossRef

Haapanen-Niemi N, Miilunpalo S, Pasanen M, Vuori I, Oja P, Malmberg J. Body mass index, physical inactivity and low level of physical fitness as determinants of all cause and cardiovascular disease mortality—16 year follow-up of middle-aged and elderly men and women. Int J Obes. 2000;24:1465–74.CrossRef

Wilson PW, D′Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk. Arch Intern Med. 2002;162:1867–72.PubMedCrossRef

Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation. 2005;112:666–73.PubMedCrossRef

Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–9.PubMedCrossRef

Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the national heart, lung and blood institute/American heart association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24:e13–8.PubMedCrossRef

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143–421.

10.

Isomaa B. A major health hazard: the metabolic syndrome. Life Sci. 2003;73:2395–411.PubMedCrossRef

11.

Puccio EM, McPhillips JB, Barrett-Connor E, Ganiats TG. Clustering of atherogenic behaviors in coffee drinkers. Am J Public Health. 1990;80:1310–3.PubMedCrossRef

12.

Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports. 2006;16(Suppl 1):3–63.PubMedCrossRef

13.

Tuomilehto J, Hu G, Bidel S, Lindström J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA. 2004;291:1213–9.PubMedCrossRef

14.

Stensvold I, Tverdal A, Foss OP. The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women, 40–42 years. J Clin Epidemiol. 1989;42:877–84.PubMedCrossRef

15.

Jee SH, He J, Whelton PK, Suh I, Klag MJ. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension. 1999;33:647–52.PubMed

16.

Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001;153:353–62.PubMedCrossRef

17.

Greenberg JA, Axen KV, Schnoll R, Boozer CN. Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes. 2005;29:1121–9.CrossRef

18.

Hino A, Adachi H, Enomoto M, Furuki K, Shigetoh Y, Ohtsuka M, et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome. An epidemiological study in a general Japanese population. Diabetes Res Clin Pract. 2007;76:383–9.PubMedCrossRef

19.

Kemper HC, editor. Amsterdam growth and health longitudinal study: a 23-year follow-up from teenager to adult about lifestyle and health. Basel, Switzerland: Karger; 2004.

20.

Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE, et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension. 2000;36:801–7.PubMed

21.

Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. The metabolic syndrome, cardiopulmonary fitness and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam growth and health longitudinal study. Arch Intern Med. 2005;165:875–82.PubMedCrossRef

22.

Morriss R, Mohammed FA. Metabolism, lifestyle and bipolar affective disorder. J Psychopharmacol. 2005;19(6 suppl):94–101.PubMedCrossRef

23.

van Dusseldorp M, Katan MB, van Vliet T, Demacker PN, Stalenhoef AF. Cholesterol-raising factor from boiled coffee does not pass a paper filter. Arterioscler Thromb Vasc Biol. 1991;11:586–93.

24.

Boekschoten MV, Engberink MF, Katan MB, Schouten EG. Reproducibility of the serum lipid response to coffee oil in healthy volunteers. Nutr J. 2003;2(1):8.PubMedCrossRef

25.

Boekschoten MV, van Cruchten ST, Kosmeijer-Schuil TG, Katan MB. Negligible amounts of cholesterol-raising diterpenes in coffee made with coffee pads in comparison with unfiltered coffee (in Dutch). Ned Tijdschr Geneeskd. 2006;52:2873–5.

26.

Strandhagen E, Thelle DS. Filtered coffee raises serum cholesterol: results from a controlled intervention trial. Eur J Clin Nutr. 2003;57:1164–8.PubMedCrossRef

27.

Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu Rev Nutr. 1997;17:305–24.PubMedCrossRef

28.

Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med. 2004;255:89–95.PubMedCrossRef

29.

van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002;360:1477–8.PubMedCrossRef

30.

Lopez-Garzia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB. Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr. 2006;83:674–80.

31.

Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled clinical trials. J Hypertens. 2005;23:921–8.PubMedCrossRef

32.

Geleijnse JM, Kok FJ, Grobbee DE. Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populations. Eur J Pub Health. 2004;14:235–9.CrossRef

33.

Stamler J, Caggiula AW, Grandits GA. Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997;65(suppl):338S–65S.PubMed

34.

Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. Habitual caffeine intake and the risk of hypertension in women. JAMA. 2005;294:2330–5.PubMedCrossRef

35.

Uiterwaal CS, Verschuren WM, Bueno-de-Mesquita HB, Ocké M, Geleijnse JM, Boshuizen HC, et al. Coffee intake and incidence of hypertension. Am J Clin Nutr. 2007;85:718–23.PubMed

36.

Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 2004;140:1–8.PubMed

37.

Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J. Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Int J Obes. 2006;30:1742–9.CrossRef

38.

van Dam RM, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes: the Hoorn study. Diabetologia. 2004;47:2152–9.PubMedCrossRef

39.

Keijzers GB, de Galan BE, Tack CJ, Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care. 2002;25:364–9.PubMedCrossRef

40.

Bos MB, de Vries JH, Wolffenbuttel BH, Verhagen H, Hillege JL, Feskens EJ. The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60 (in Dutch). Ned Tijdschr Geneeskd. 2007;151:2382–8.PubMed

Title: Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study
Authors: Lisanne Balk
Trynke Hoekstra
Jos Twisk
Publication date: 01-04-2009
Publisher: Springer Netherlands
Published in: European Journal of Epidemiology / Issue 4/2009
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-009-9323-1

At a glance: The STEP trials

Springer Medicine

Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2009

Measures of physical activity and their correlates: The Swedish National March Cohort

Medical demography and epidemiology: dizygotic twins

Relationships of self-reported physical activity domains with accelerometry recordings in French adults

How far can we explain the social class differential in respiratory function? A cross-sectional population study of 21,991 men and women from EPIC-Norfolk

Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis

Rise in psychotropic drug prescribing in children and adolescents during 1992–2001: a population-based study in the UK